Still a massive gap in the mobile e-health market that EPAT can fill.
The market is estimated to be worth $26 billion in 2017 ( and growing at +15% annually in the next few years) but to date, there doesn't seem to be any effective pain management/recognition apps that have a strong clinical backing which is where EPAT can disrupt.
Source: Journal article Published 26 September 2016 (download to view full)
https://www.dovepress.com/smartphon...-a-critical-apprais-peer-reviewed-article-JPR
- Forums
- ASX - By Stock
- Ann: Change of Company Name-MNQ.AX
Still a massive gap in the mobile e-health market that EPAT can...
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online